HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 295 filers reported holding HAEMONETICS CORP in Q3 2018. The put-call ratio across all filers is 1.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $1,272,000 | +8.5% | 10,080 | +3.4% | 0.02% | +8.7% |
| Q2 2019 | $1,172,000 | +37.6% | 9,744 | 0.0% | 0.02% | +35.3% |
| Q1 2019 | $852,000 | -9.5% | 9,744 | +3.6% | 0.02% | -22.7% |
| Q4 2018 | $941,000 | -12.7% | 9,408 | 0.0% | 0.02% | +4.8% |
| Q3 2018 | $1,078,000 | +63.8% | 9,408 | +28.2% | 0.02% | +50.0% |
| Q2 2018 | $658,000 | -31.7% | 7,336 | -50.0% | 0.01% | +40.0% |
| Q1 2018 | $963,000 | +126.1% | 14,672 | +100.0% | 0.01% | +11.1% |
| Q4 2017 | $426,000 | +56.0% | 7,336 | +20.7% | 0.01% | +50.0% |
| Q3 2017 | $273,000 | +26.4% | 6,076 | +11.3% | 0.01% | +20.0% |
| Q2 2017 | $216,000 | +81.5% | 5,460 | +85.7% | 0.01% | +66.7% |
| Q1 2017 | $119,000 | +0.8% | 2,940 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $118,000 | – | 2,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BEACONLIGHT CAPITAL, LLC | 95,033 | $8,511,000 | 2.84% |
| Advantage Alpha Capital Partners LP | 100,170 | $8,971,000 | 2.10% |
| Nitorum Capital, L.P. | 395,635 | $35,433,000 | 1.82% |
| Summit Creek Advisors LLC | 127,600 | $11,428,000 | 1.68% |
| Bridge City Capital, LLC | 40,559 | $3,632,000 | 1.67% |
| AEGON ASSET MANAGEMENT UK PLC | 520,408 | $46,603,000 | 1.05% |
| Jackson Square Partners, LLC | 2,298,190 | $205,825,000 | 1.03% |
| Parkman Healthcare Partners LLC | 30,147 | $2,700,000 | 0.76% |
| TEALWOOD ASSET MANAGEMENT INC | 9,154 | $820,000 | 0.54% |
| AMERICAN CAPITAL MANAGEMENT INC | 159,145 | $14,253,000 | 0.52% |